Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Metabolite Changes in the Posterior Cingulate Cortex Could Be a Signature for Early Detection of Alzheimer’S Disease: A Systematic Review and Meta-Analysis Study Based on 1H-Nmr Publisher



Rahim F1 ; Khalafi M2 ; Davoodi M3 ; Shirbandi K4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Anesthesia, Cihan University - Sulaimaniya, Kurdistan Region, Sulaymaniyah, Iraq
  2. 2. School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
  3. 3. Department of Radiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran

Source: Egyptian Journal of Neurology# Psychiatry and Neurosurgery Published:2023


Abstract

Background: Posterior cingulate cortex (PCC) is a paralimbic cortical structure with a fundamental role in integrative functions of the default mode network (DMN). PCC activation and deactivation of interconnected structures within the medial temporal lobe is essential in memory recall. Aim: Assessing the metabolomics content changes in PCC of the patients with Alzheimer’s disease (AD) compared to healthy controls (HC) to find a new method for early AD detection was the primary goal of this study. Methods: We performed a comprehensive search through eight international indexing databases. Searches were done using the medical subject headings (Mesh) keywords. Outcome measures included Population (HC/AD), Age (y), Gender (Male/Female), MRI equipment, Tesla (T), MMSE (mean ± SD), absolute and ratio absolutes metabolites in the PCC. All meta-analyses were performed using STATA V.14 tools to provide pooled figures. Results: Studies published from 1980 to 2019 using the 1H-NMR technique of 3,067 screened studies, 18 studies comprising 1647 people (658 males and 941 females, 921 HC and 678 AD cases) were included. The results revealed a significant increase in mI content and a substantial decrease in NAA, Glu, and Glx levels of the PCC in AD patients compared to HC. Conclusions: Our meta-analysis showed that microstructural disruptions in the PCC could be used as a marker for early AD detection. Although NAA, mI, Glu, and (NAA, Cho, and mI)/Cr biomarkers are substantial metabolites for diagnosis and are most sensitive for diagnosis. Trial registration PROSPERO Registration: CRD42018099325 . © 2023, The Author(s).
Experts (# of related papers)
Other Related Docs
19. Aducanumab: An Uprising Hope With Vague Horizons, Egyptian Journal of Neurology# Psychiatry and Neurosurgery (2023)
27. Combination Therapy in Alzheimer's Disease: Is It Time?, Journal of Alzheimer's Disease (2022)
33. Cortical and Subcortical Structural Segmentation in Alzheimer’S Disease, Frontiers in Biomedical Technologies (2019)